A Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palbociclib Treatment Using a Real-world Database

Not yet recruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

November 28, 2025

Study Completion Date

November 28, 2025

Conditions

Advanced or Metastatic Breast Cancer

Interventions

DRUG

Ibrance

Patients who received at least one initial prescription of Ibrance following a diagnosis of advanced/metastatic breast cancer